http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021167894-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d50a5d08fff80f620aa6f328cd9bc85e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fcb093a174d5182b5854b704cb09354
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
filingDate 2021-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46921aa67f55d6da2c24535cd0f547bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0d993816bb1f6c751140e1e2f560825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41f18d43ec0b5d43ceafccd87f7dfcfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6b74117bea6834d2cd3455719cb116a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d392264b1e15f8f46f84a5012298713
publicationDate 2021-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021167894-A1
titleOfInvention Compositions and methods for treating malaria
abstract Disclosed are methods of treating malaria with tetrahydrobenzonaphtyridine carboxanilide (TBN) derivatives and related pyrrolinones and hydrolysis products thereof. These compounds are active against Plasmodium falciparum strains that are resistant to multiple drugs currently on the market. The present invention further relates to novel compounds and pharmaceutical compositions comprising such compounds.
priorityDate 2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016202898-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465884458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466464270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465175900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468121805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467061979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465885473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164063533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164064238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456937832

Total number of triples: 37.